554 related articles for article (PubMed ID: 31104052)
1. SCCA-IgM as a Potential Biomarker of Non-Alcoholic Fatty Liver Disease in Patients with Obesity, Prediabetes and Diabetes Undergoing Sleeve Gastrectomy.
Bettini S; Bordigato E; Milan G; Dal Pra' C; Favaretto F; Belligoli A; Sanna M; Serra R; Foletto M; Prevedello L; Busetto L; Fassina G; Vettor R; Fabris R
Obes Facts; 2019; 12(3):291-306. PubMed ID: 31104052
[TBL] [Abstract][Full Text] [Related]
2. The HAALT Non-invasive Scoring System for NAFLD in Obesity.
Sheth H; Bagasrawala S; Shah M; Ansari R; Olithselvan A; Lakdawala M
Obes Surg; 2019 Aug; 29(8):2562-2570. PubMed ID: 31016455
[TBL] [Abstract][Full Text] [Related]
3. Laparoscopic Sleeve Gastrectomy on the Horizon as a Promising Treatment Modality for NAFLD.
Salman MA; Salman AA; Abdelsalam A; Atallah M; Shaaban HE; El-Mikkawy A; Omar MG; Elshenoufy M
Obes Surg; 2020 Jan; 30(1):87-95. PubMed ID: 31372873
[TBL] [Abstract][Full Text] [Related]
4. Bariatric Surgery as an Efficient Treatment for Non-Alcoholic Fatty Liver Disease in a Prospective Study with 1-Year Follow-up : BariScan Study.
Nickel F; Tapking C; Benner L; Sollors J; Billeter AT; Kenngott HG; Bokhary L; Schmid M; von Frankenberg M; Fischer L; Mueller S; Müller-Stich BP
Obes Surg; 2018 May; 28(5):1342-1350. PubMed ID: 29119336
[TBL] [Abstract][Full Text] [Related]
5. HCV genotype 3 and squamous cell carcinoma antigen (SCCA)-IgM are independently associated with histological features of NASH in HCV-infected patients.
Martini A; Fattovich G; Guido M; Bugianesi E; Biasiolo A; Ieluzzi D; Gallotta A; Fassina G; Merkel C; Gatta A; Negro F; Pontisso P
J Viral Hepat; 2015 Oct; 22(10):800-8. PubMed ID: 25611978
[TBL] [Abstract][Full Text] [Related]
6. Improvement of nonalcoholic fatty liver disease in morbidly obese patients after sleeve gastrectomy: association of ultrasonographic findings with lipid profile and liver enzymes.
Ruiz-Tovar J; Alsina ME; Alpera MR;
Acta Chir Belg; 2017 Dec; 117(6):363-369. PubMed ID: 28585487
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of endoscopic sleeve gastroplasty versus laparoscopic sleeve gastrectomy in obese subjects with Non-Alcoholic SteatoHepatitis (NASH): study protocol for a randomized controlled trial (TESLA-NASH study).
Lavín-Alconero L; Fernández-Lanas T; Iruzubieta-Coz P; Arias-Loste MT; Rodriguez-Duque JC; Rivas C; Cagigal ML; Montalbán C; Useros AL; Álvarez-Cancelo A; García-Saiz M; Crespo-García J
Trials; 2021 Oct; 22(1):756. PubMed ID: 34717726
[TBL] [Abstract][Full Text] [Related]
8. A Pilot Study of Serum Sphingomyelin Dynamics in Subjects with Severe Obesity and Non-alcoholic Steatohepatitis after Sleeve Gastrectomy.
Ramos-Molina B; Castellano-Castillo D; Pastor O; Ocaña-Wilhelmi L; Fernández-García D; Romero-Gómez M; Cardona F; Tinahones FJ
Obes Surg; 2019 Mar; 29(3):983-989. PubMed ID: 30488259
[TBL] [Abstract][Full Text] [Related]
9. Development of a novel diagnostic algorithm to predict NASH in HCV-positive patients.
Gallotta A; Paneghetti L; Mrázová V; Bednárová A; Kružlicová D; Frecer V; Miertus S; Biasiolo A; Martini A; Pontisso P; Fassina G
Int J Biol Markers; 2018 May; 33(2):231-236. PubMed ID: 29712495
[TBL] [Abstract][Full Text] [Related]
10. Laparoscopic sleeve gastrectomy reverses non-alcoholic fatty liver disease modulating oxidative stress and inflammation.
Cabré N; Luciano-Mateo F; Fernández-Arroyo S; Baiges-Gayà G; Hernández-Aguilera A; Fibla M; Fernández-Julià R; París M; Sabench F; Castillo DD; Menéndez JA; Camps J; Joven J
Metabolism; 2019 Oct; 99():81-89. PubMed ID: 31279739
[TBL] [Abstract][Full Text] [Related]
11. Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology.
Calvo N; Beltrán-Debón R; Rodríguez-Gallego E; Hernández-Aguilera A; Guirro M; Mariné-Casadó R; Millá L; Alegret JM; Sabench F; del Castillo D; Vinaixa M; Rodríguez MÀ; Correig X; García-Álvarez R; Menendez JA; Camps J; Joven J
World J Gastroenterol; 2015 Jun; 21(24):7529-44. PubMed ID: 26140000
[TBL] [Abstract][Full Text] [Related]
12. Laparoscopic Sleeve Gastrectomy Resolves NAFLD: Another Formal Indication for Bariatric Surgery?
Esquivel CM; Garcia M; Armando L; Ortiz G; Lascano FM; Foscarini JM
Obes Surg; 2018 Dec; 28(12):4022-4033. PubMed ID: 30121855
[TBL] [Abstract][Full Text] [Related]
13. Combined Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Sleeve Gastrectomy or Gastric Bypass?-a Controlled Matched Pair Study of 34 Patients.
Billeter AT; Senft J; Gotthardt D; Knefeli P; Nickel F; Schulte T; Fischer L; Nawroth PP; Büchler MW; Müller-Stich BP
Obes Surg; 2016 Aug; 26(8):1867-74. PubMed ID: 26660688
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of prediabetes and diabetes in children and adolescents with biopsy-proven non-alcoholic fatty liver disease.
Nobili V; Mantovani A; Cianfarani S; Alisi A; Mosca A; Sartorelli MR; Maffeis C; Loomba R; Byrne CD; Targher G
J Hepatol; 2019 Oct; 71(4):802-810. PubMed ID: 31279904
[TBL] [Abstract][Full Text] [Related]
15. Experimental validation of specificity of the squamous cell carcinoma antigen-immunoglobulin M (SCCA-IgM) assay in patients with cirrhosis.
Zuin J; Veggiani G; Pengo P; Gallotta A; Biasiolo A; Tono N; Gatta A; Pontisso P; Toth R; Cerin D; Frecer V; Meo S; Gion M; Fassina G; Beneduce L
Clin Chem Lab Med; 2010 Feb; 48(2):217-23. PubMed ID: 20001440
[TBL] [Abstract][Full Text] [Related]
16. Bile acid, glucose, lipid profile, and liver enzyme changes in prediabetic patients 1 year after sleeve gastrectomy.
Mak TK; Huang S; Guan B; Au H; Chong TH; Peng J; Chen F; Liang C; Lai W; Ho L; Wang C; Yang J
BMC Surg; 2020 Dec; 20(1):329. PubMed ID: 33317506
[TBL] [Abstract][Full Text] [Related]
17. Non-alcoholic fatty liver disease resolution following sleeve gastrectomy.
Algooneh A; Almazeedi S; Al-Sabah S; Ahmed M; Othman F
Surg Endosc; 2016 May; 30(5):1983-7. PubMed ID: 26194256
[TBL] [Abstract][Full Text] [Related]
18. Effects of Laparoscopic Sleeve Gastrectomy on Non-Alcoholic Steatohepatitis and Liver Fibrosis in Japanese Patients with Severe Obesity.
Nikai H; Ishida K; Umemura A; Baba S; Nitta H; Sugai T; Sasaki A
Obes Surg; 2020 Jul; 30(7):2579-2587. PubMed ID: 32124215
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and Predictors of Non-Alcoholic Fatty Liver Disease in Morbidly Obese South Indian Patients Undergoing Bariatric Surgery.
Praveenraj P; Gomes RM; Kumar S; Karthikeyan P; Shankar A; Parthasarathi R; Senthilnathan P; Rajapandian S; Palanivelu C
Obes Surg; 2015 Nov; 25(11):2078-87. PubMed ID: 25835982
[TBL] [Abstract][Full Text] [Related]
20. Features of nonalcoholic steatohepatitis in severely obese children and adolescents undergoing sleeve gastrectomy.
Alqahtani A; Elahmedi M; Alswat K; Arafah M; Fagih M; Lee J
Surg Obes Relat Dis; 2017 Sep; 13(9):1599-1609. PubMed ID: 28600116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
